One huge reason why the world of medicine hasn't yet found "the cure" for hard-to-treat malignancies like acute myeloid ...

Hidden within our bones, marrow sustains life by producing billions of blood cells daily, from oxygen-carrying red cells to immune-boosting white cells. This vital function is often disrupted in ...

Crown Bioscience developed a 3D bone marrow niche (BMN) model to advance preclinical drug screening for hematological malignancies such as acute myeloid leukemia (AML) and multiple myeloma (MM). The ...

STUDIO CITY, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) and Black Swan Research Initiative ® (BSRI) announced the recently published cohort study by the ...

In a Phase II trial, LEVI-04 demonstrated a significant, dose-dependent reduction in bone marrow lesions (BML) compared with placebo in patients ...

The intervention being tested is the CardiAMP cell therapy system, which involves the use of autologous bone marrow mononuclear cells (ABM MNC). These cells are harvested from the patient’s bone ...

“[…] we were able to reproduce systemic rejuvenating effects of circulating blood factors on the human skin, which have been so far only demonstrated in rodent ...

In multiple myeloma, abnormal plasma cells build up inside bone marrow -- the spongy tissue inside large bones where blood cells are produced. Over time, myeloma cells cause damage to bones, kidneys, ...

Bone marrow aspirate concentrate (BMAC) is a common treatment for joint injuries. The invasive therapy involves extracting ...

Hidden within our bones, marrow sustains life by producing billions of blood cells daily, from oxygen-carrying red cells to immune-boosting white cells. This vital function is often disrupted in ...